|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000116473 |
Summary for RAP1A |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000116473 | Gene symbol | RAP1A |
| Gene name | RAP1A, member of RAS oncogene family | |
| HGNC | 9855 | |
| Entrez ID | 5906 | |
| Gene type | protein_coding | |
| Synonyms | RAP1A|KREV-1|SMGP21 | |
| UniProtAcc | P62834 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for RAP1A |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| RAP1A | 5.46e+03 | -1.29e+00 | 1.41e-01 | -9.13e+00 | 7.01e-20 | 7.18e-18 | STAD |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| RAP1A | 2.27e+03 | -1.82e+00 | 2.13e-01 | -8.55e+00 | 1.18e-17 | 1.66e-15 | READ |
Top |
Sex-biased somatic mutation for RAP1A |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for RAP1A |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Top |
Exon skipping events with PSI in TCGA for RAP1A |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for RAP1A |
| ∗Please access CAeditome for RNA editing annotation. |
| Landscape of RNA editing events across multiple cancer types. |
 |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| STAD | RAP1A-004 | chr1_111668773_+ | 2.43e-01 | 1.41e-01 | 2.43e+00 | 1.52e-02 | 4.96e-02 | 1.02e-01 |
| STAD | RAP1A-004 | chr1_111668909_+ | 2.38e-01 | 1.69e-01 | 2.26e+00 | 2.38e-02 | 4.96e-02 | 6.81e-02 |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for RAP1A |
| TFs related to RAP1A. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| DLBC | PRDM6 | RAP1A | 4.33e+00 | 9.87e-01 | 3.22e+00 | 3.67e-03 | Male-biased |
| DLBC | ZNF182 | RAP1A | 4.23e+00 | 9.85e-01 | 3.16e+00 | 4.23e-03 | Male-biased |
| DLBC | ZNF22 | RAP1A | 4.27e+00 | 9.87e-01 | 3.13e+00 | 3.25e-03 | Male-biased |
| DLBC | ZNF235 | RAP1A | 4.50e+00 | 9.92e-01 | 3.10e+00 | 1.31e-03 | Male-biased |
| DLBC | ZNF287 | RAP1A | 4.35e+00 | 9.89e-01 | 3.07e+00 | 1.97e-03 | Male-biased |
| DLBC | ZNF418 | RAP1A | 5.32e+00 | 9.89e-01 | 4.44e+00 | 9.32e-03 | Male-biased |
| DLBC | ZNF487 | RAP1A | 4.36e+00 | 9.88e-01 | 3.23e+00 | 3.41e-03 | Male-biased |
| DLBC | ZNF492 | RAP1A | 4.26e+00 | 9.81e-01 | 3.35e+00 | 8.06e-03 | Male-biased |
| DLBC | ZNF613 | RAP1A | 4.35e+00 | 9.82e-01 | 3.46e+00 | 8.85e-03 | Male-biased |
| DLBC | ZNF879 | RAP1A | 4.89e+00 | 9.88e-01 | 3.98e+00 | 8.14e-03 | Male-biased |
| MESO | AIRE | RAP1A | 4.60e+00 | 9.93e-01 | 2.87e+00 | 1.65e-03 | Male-biased |
| MESO | BCL6B | RAP1A | 4.15e+00 | 9.81e-01 | 2.84e+00 | 6.84e-03 | Male-biased |
| MESO | CDX2 | RAP1A | 4.33e+00 | 9.91e-01 | 2.19e+00 | 3.61e-04 | Male-biased |
| MESO | E2F7 | RAP1A | 4.26e+00 | 9.85e-01 | 2.86e+00 | 5.26e-03 | Male-biased |
| MESO | EVX2 | RAP1A | 4.18e+00 | 9.88e-01 | 2.30e+00 | 9.23e-04 | Male-biased |
| MESO | FOXD2 | RAP1A | 4.57e+00 | 9.94e-01 | 2.21e+00 | 1.67e-04 | Male-biased |
| MESO | FOXE1 | RAP1A | 3.96e+00 | 9.85e-01 | 1.77e+00 | 2.96e-04 | Male-biased |
| MESO | FOXG1 | RAP1A | 3.90e+00 | 9.83e-01 | 1.25e+00 | 6.25e-05 | Male-biased |
| MESO | FOXJ2 | RAP1A | 3.82e+00 | 9.81e-01 | 1.64e+00 | 3.05e-04 | Male-biased |
| MESO | FOXL1 | RAP1A | 3.96e+00 | 9.85e-01 | 1.47e+00 | 1.04e-04 | Male-biased |
| MESO | FOXQ1 | RAP1A | 4.45e+00 | 9.93e-01 | 2.25e+00 | 2.96e-04 | Male-biased |
| MESO | HOXC10 | RAP1A | 4.45e+00 | 9.93e-01 | 2.33e+00 | 3.90e-04 | Male-biased |
| MESO | IRF1 | RAP1A | 4.07e+00 | 9.87e-01 | 1.85e+00 | 2.68e-04 | Male-biased |
| MESO | MEF2A | RAP1A | 3.93e+00 | 9.84e-01 | 1.56e+00 | 1.61e-04 | Male-biased |
| MESO | MSX1 | RAP1A | 4.48e+00 | 9.93e-01 | 2.19e+00 | 2.19e-04 | Male-biased |
| MESO | MSX2 | RAP1A | 4.52e+00 | 9.94e-01 | 2.20e+00 | 2.01e-04 | Male-biased |
| MESO | MYNN | RAP1A | 4.19e+00 | 9.89e-01 | 2.04e+00 | 3.47e-04 | Male-biased |
| MESO | POU2F1 | RAP1A | 4.32e+00 | 9.91e-01 | 2.42e+00 | 8.64e-04 | Male-biased |
| MESO | POU3F2 | RAP1A | 4.12e+00 | 9.88e-01 | 1.55e+00 | 8.06e-05 | Male-biased |
| MESO | SOX15 | RAP1A | 4.81e+00 | 9.95e-01 | 2.79e+00 | 5.88e-04 | Male-biased |
| MESO | SOX9 | RAP1A | 4.32e+00 | 9.91e-01 | 2.09e+00 | 2.66e-04 | Male-biased |
| MESO | STAT5B | RAP1A | 4.26e+00 | 9.90e-01 | 2.34e+00 | 8.28e-04 | Male-biased |
| MESO | YY1 | RAP1A | 4.14e+00 | 9.86e-01 | 2.55e+00 | 2.58e-03 | Male-biased |
| MESO | ZNF136 | RAP1A | 4.20e+00 | 9.89e-01 | 2.32e+00 | 9.41e-04 | Male-biased |
| MESO | ZNF175 | RAP1A | 4.27e+00 | 9.90e-01 | 2.05e+00 | 2.77e-04 | Male-biased |
| MESO | ZNF25 | RAP1A | 4.01e+00 | 9.86e-01 | 1.34e+00 | 6.02e-05 | Male-biased |
| MESO | ZNF250 | RAP1A | 4.59e+00 | 9.93e-01 | 2.79e+00 | 1.28e-03 | Male-biased |
| MESO | ZNF276 | RAP1A | 5.24e+00 | 9.88e-01 | 4.01e+00 | 9.63e-03 | Male-biased |
| MESO | ZNF317 | RAP1A | 4.44e+00 | 9.91e-01 | 2.70e+00 | 1.58e-03 | Male-biased |
| MESO | ZNF354B | RAP1A | 4.55e+00 | 9.93e-01 | 2.54e+00 | 6.11e-04 | Male-biased |
| MESO | ZNF418 | RAP1A | 4.07e+00 | 9.87e-01 | 3.88e-01 | 2.23e-06 | Male-biased |
| MESO | ZNF74 | RAP1A | 4.40e+00 | 9.90e-01 | 2.80e+00 | 2.64e-03 | Male-biased |
| PCPG | SOX15 | RAP1A | 4.29e+00 | 9.84e-01 | 3.37e+00 | 5.68e-03 | Male-biased |
| RAP1A related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for RAP1A |
| RBPs related to ES in RAP1A. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| THYM | CNOT4 | exon_skip_8907 | 8.47e+00 | 3.49e-03 | 8.88e+00 | 9.92e-01 | Female-biased |
| PAAD | CNOT4 | exon_skip_8907 | 8.85e+00 | 9.93e-01 | 8.45e+00 | 2.57e-03 | Male-biased |
| RAP1A related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs11801226 | chr1:107732983:A:T | - | 0.172312703505273 | 0.00469994360678022 | LUSC | Female-baised eQTL |
| rs148443508 | chr1:107736843:A:G | - | 0.180211613153842 | 0.0117686822533218 | LUSC | Female-baised eQTL |
| rs147762141 | chr1:107737482:C:T | - | 0.180211613153842 | 0.0117686822533218 | LUSC | Female-baised eQTL |
| rs12406345 | chr1:107740025:G:A | - | 0.180211613153842 | 0.0117686822533218 | LUSC | Female-baised eQTL |
| rs12405204 | chr1:107739590:A:T | - | 0.179780902773191 | 0.0124314387737912 | LUSC | Female-baised eQTL |
| rs17019880 | chr1:107745598:T:C | - | 0.176641288562519 | 0.0164578584020699 | LUSC | Female-baised eQTL |
| rs72705642 | chr1:107746647:G:T | - | 0.176641288562519 | 0.0164578584020699 | LUSC | Female-baised eQTL |
| rs6670623 | chr1:104709296:G:C | - | 0.0783965250760589 | 0.0347389035451056 | LGG | Female-baised eQTL |
| rs5015332 | chr1:103848043:C:T | - | 0.0613458398383546 | 0.0155219386661874 | LUAD | Female-baised eQTL |
| rs7513434 | chr1:110643707:C:T | - | 0.0785518477717979 | 0.0409076581455395 | LUAD | Female-baised eQTL |
| rs1021880 | chr1:109881907:A:G | - | 0.0950423840617522 | 0.0427226565158242 | LUAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs2488756 | chr1:112408668:C:T | - | 0.878088758140217 | 1.46251350632236e-10 | PCPG | Male-baised eQTL |
| rs2483331 | chr1:112410341:A:C | - | 0.878088758140217 | 1.46251350632236e-10 | PCPG | Male-baised eQTL |
| rs12062571 | chr1:109974995:T:C | - | 0.217367589753066 | 0.000639975574495508 | PCPG | Male-baised eQTL |
| rs269139 | chr1:112076834:G:T | - | 0.215013457012007 | 0.00366566054339111 | PCPG | Male-baised eQTL |
| rs2492508 | chr1:112398512:G:A | - | 0.441777208965142 | 0.00720869312556022 | PCPG | Male-baised eQTL |
| rs2995761 | chr1:112398941:T:G | - | 0.441777208965142 | 0.00720869312556022 | PCPG | Male-baised eQTL |
| rs2488760 | chr1:112399517:A:G | - | 0.441777208965142 | 0.00720869312556022 | PCPG | Male-baised eQTL |
| rs1891706 | chr1:112399962:G:A | - | 0.441777208965142 | 0.00720869312556022 | PCPG | Male-baised eQTL |
| rs2999473 | chr1:112400828:G:A | - | 0.441777208965142 | 0.00720869312556022 | PCPG | Male-baised eQTL |
| rs2999474 | chr1:112400961:G:A | - | 0.441777208965142 | 0.00720869312556022 | PCPG | Male-baised eQTL |
| rs2999475 | chr1:112401075:G:A | - | 0.441777208965142 | 0.00720869312556022 | PCPG | Male-baised eQTL |
| rs1936047 | chr1:112403737:C:T | - | 0.441777208965142 | 0.00720869312556022 | PCPG | Male-baised eQTL |
| rs1777604 | chr1:112407256:A:G | - | 0.441777208965142 | 0.00720869312556022 | PCPG | Male-baised eQTL |
| rs798016 | chr1:116799778:C:T | - | 0.18379913471644 | 0.0130208363810823 | PCPG | Male-baised eQTL |
| rs798005 | chr1:116802737:C:T | - | 0.18379913471644 | 0.0130208363810823 | PCPG | Male-baised eQTL |
| rs798027 | chr1:116795558:A:T | - | 0.175429554185379 | 0.0324810430114959 | PCPG | Male-baised eQTL |
| rs798026 | chr1:116795566:T:A | - | 0.175429554185379 | 0.0324810430114959 | PCPG | Male-baised eQTL |
| rs7527471 | chr1:106597490:T:C | - | 0.164512570201704 | 0.0335459304923936 | PCPG | Male-baised eQTL |
| rs1088460 | chr1:116788073:T:A | - | 0.174182503830276 | 0.0367443199529559 | PCPG | Male-baised eQTL |
| rs73009073 | chr1:116791892:G:A | - | 0.174182503830276 | 0.0367443199529559 | PCPG | Male-baised eQTL |
| rs10923147 | chr1:116792719:C:G | - | 0.174182503830276 | 0.0367443199529559 | PCPG | Male-baised eQTL |
| rs6701708 | chr1:111969573:C:T | - | 0.0782686215503278 | 0.0298460687032515 | LGG | Male-baised eQTL |
| rs10747433 | chr1:102952517:A:C | - | -0.0728969678703956 | 0.0405165879243737 | BLCA | Male-baised eQTL |
| rs1966958 | chr1:102953541:A:G | - | -0.0728969678703956 | 0.0405165879243737 | BLCA | Male-baised eQTL |
| rs10754372 | chr1:118209333:G:C | - | 0.0330548865277236 | 0.0437846547805348 | BLCA | Male-baised eQTL |
| rs12140435 | chr1:118209995:G:A | - | 0.0332219704700232 | 0.0440986278536614 | BLCA | Male-baised eQTL |
| rs10923519 | chr1:118210207:T:G | - | 0.0330146052869047 | 0.0448464072781745 | BLCA | Male-baised eQTL |
| rs2154354 | chr1:118212640:G:C | - | 0.0330146052869047 | 0.0448464072781745 | BLCA | Male-baised eQTL |
| rs4658975 | chr1:118214137:A:G | - | 0.0330146052869047 | 0.0448464072781745 | BLCA | Male-baised eQTL |
| rs12136216 | chr1:118209785:A:G | - | 0.0329097644239429 | 0.0472913069956321 | BLCA | Male-baised eQTL |
| rs12137016 | chr1:118210017:A:G | - | 0.0329097644239429 | 0.0472913069956321 | BLCA | Male-baised eQTL |
| rs7535558 | chr1:109908496:T:C | - | -0.0374027823194817 | 0.0485716247559867 | BLCA | Male-baised eQTL |
| rs2615984 | chr1:102958032:A:G | - | -0.070622239007415 | 0.0497404614042872 | BLCA | Male-baised eQTL |
| rs2615985 | chr1:102959396:G:A | - | -0.070622239007415 | 0.0497404614042872 | BLCA | Male-baised eQTL |
| rs1841834 | chr1:102962833:G:A | - | -0.070622239007415 | 0.0497404614042872 | BLCA | Male-baised eQTL |
| rs11164647 | chr1:102967131:T:C | - | -0.070622239007415 | 0.0497404614042872 | BLCA | Male-baised eQTL |
| rs6662599 | chr1:102967386:A:G | - | -0.070622239007415 | 0.0497404614042872 | BLCA | Male-baised eQTL |
| rs2615990 | chr1:102968914:G:A | - | -0.070622239007415 | 0.0497404614042872 | BLCA | Male-baised eQTL |
| rs1537955 | chr1:102010756:T:C | - | 0.0674102318808957 | 0.00530690890194706 | COAD | Male-baised eQTL |
| rs17484544 | chr1:115461911:C:T | - | 0.08885234297065 | 0.00533345265472186 | COAD | Male-baised eQTL |
| rs12030625 | chr1:110573333:G:C | - | 0.0697325171670035 | 0.00605356057333975 | COAD | Male-baised eQTL |
| rs498439 | chr1:115451055:G:T | - | 0.0844010108406501 | 0.0063896495773844 | COAD | Male-baised eQTL |
| rs17539492 | chr1:107679844:T:G | - | 0.0948942191797181 | 0.00709355987712797 | COAD | Male-baised eQTL |
| rs61803527 | chr1:102018242:T:C | - | 0.0646723765664468 | 0.00854466928534833 | COAD | Male-baised eQTL |
| rs486296 | chr1:115447162:A:G | - | 0.0843598525535515 | 0.00894340155228 | COAD | Male-baised eQTL |
| rs563998 | chr1:115447515:A:C | - | 0.0843598525535515 | 0.00894340155228 | COAD | Male-baised eQTL |
| rs563992 | chr1:115447521:A:G | - | 0.0843598525535515 | 0.00894340155228 | COAD | Male-baised eQTL |
| rs527278 | chr1:115449235:G:T | - | 0.0843598525535515 | 0.00894340155228 | COAD | Male-baised eQTL |
| rs532431 | chr1:115449602:A:G | - | 0.0843598525535515 | 0.00894340155228 | COAD | Male-baised eQTL |
| rs61799134 | chr1:115452560:G:T | - | 0.0818477955253376 | 0.00923968121515735 | COAD | Male-baised eQTL |
| rs17556126 | chr1:115455859:T:G | - | 0.0844854494062287 | 0.00993886556886414 | COAD | Male-baised eQTL |
| rs72731691 | chr1:102022988:C:T | - | 0.0637777161686757 | 0.0107361687734343 | COAD | Male-baised eQTL |
| rs476283 | chr1:115447354:C:T | - | 0.081976689829211 | 0.0127528582734032 | COAD | Male-baised eQTL |
| rs563980 | chr1:115447525:G:A | - | 0.081976689829211 | 0.0127528582734032 | COAD | Male-baised eQTL |
| rs7529711 | chr1:102009187:T:C | - | 0.0607151084757426 | 0.0198367720810695 | COAD | Male-baised eQTL |
| rs538861 | chr1:115445146:A:G | - | 0.0791202197938308 | 0.0239637076818552 | COAD | Male-baised eQTL |
| rs17484432 | chr1:115458858:T:C | - | 0.0761862235604413 | 0.0244906604370917 | COAD | Male-baised eQTL |
| rs17556264 | chr1:115459363:A:G | - | 0.0761862235604413 | 0.0244906604370917 | COAD | Male-baised eQTL |
| rs80057683 | chr1:115701545:C:T | - | 0.0692998401122494 | 0.0252404662515202 | COAD | Male-baised eQTL |
| rs508813 | chr1:115446092:T:C | - | 0.0767070663618426 | 0.0274580235417329 | COAD | Male-baised eQTL |
| rs7541344 | chr1:115709305:C:A | - | 0.0682625030515667 | 0.0277757258558873 | COAD | Male-baised eQTL |
| rs4915034 | chr1:107305328:G:A | - | 0.113729968941062 | 0.0289706869548008 | COAD | Male-baised eQTL |
| rs2336126 | chr1:108098283:A:G | - | -0.0591383960650709 | 0.041244843189743 | COAD | Male-baised eQTL |
| rs3811013 | chr1:115691462:T:A | - | 0.0649823845404173 | 0.0422014912591388 | COAD | Male-baised eQTL |
| rs11578766 | chr1:115704057:G:A | - | 0.0639890631001209 | 0.044326097914258 | COAD | Male-baised eQTL |
| rs2645288 | chr1:118957860:G:C | - | -0.0686711132036255 | 0.0446609390822119 | COAD | Male-baised eQTL |
| rs35939222 | chr1:115703922:A:C | - | 0.0636752126101175 | 0.0458749286004727 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000116473 |
| CpG Site: cg01918604 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.316858519336588 |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg01918604 | chr1:111565319 | gene | -0.316858519336588 | 3.03486525609685e-06 | -0.39658546007930584 | 1.229522866545862e-06 | SARC |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of RAP1A |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
